跳至主要内容
临床试验/CTRI/2022/12/048178
CTRI/2022/12/048178尚未招募未知

comparative evaluation of dexmedetomidine versus nalbuphine for control of post spinal shivering - DEX NA

dr d y patil vidyapeeth pimpri pune0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • ASA grade I & II.
  • 2. Age between 18 and 60 years of either sex.
  • 3. Patients undergoing surgeries under spinal anaesthesia.
  • 4. Haemodynamically stable patients with all routine investigations within normal limits.
  • 5. Patients who are not on any cardiac related drugs
  • 5. Availability of an informed consent.

排除标准

  • . Patient refusal.
  • 2. Patients with ASA physical status III or more.
  • 3. Patients receiving sedative/ hypnotic agents.
  • 4. Patients with uncontrolled hypertension, hyperthyroidism, hypothyroidism, psychiatric disorders, severe diabetes or autonomic neuropathy.
  • 5. Patients with history of cardiac, respiratory, renal or hepatic diseases.
  • 6. Patients with history of alcohol or drug abuse.
  • 7. Patients who have a history of allergy to any of the test drugs.
  • 8. Contraindications to spinal anaesthesia (coagulation disorder, infection at puncture site, raised intracranial tension, pre-existing neurological deficit in lower extremities or any spine deformity).
  • 9. Initial body temperature >38°C or <36°C

研究者

发起方
dr d y patil vidyapeeth pimpri pune

相似试验